Temozolomide (TMZ) and radiation (XRT) for brain metastases of solid tumors

被引：0
|
作者：
Del Prete, Salvatore
Faiola, Vincenzo
Montella, Liliana
Guarrasi, Rosario
Caraglia, Michelle
Addeo, Raffaele
机构：
[1] UOC Oncol, ASLNA3 Frattamaggiore Napoli, Naples, Italy
[2] UOC Farmacol Sperimentale, INT Pascale, Naples, Italy
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [1] Temozolomide (TMZ) and radiation (XRT) for brain metastasis of solid tumors
    Addeo, R.
    Dello Russo, A. M.
    Ferraro, G.
    Capasso, E.
    Faiola, V.
    Vincenzi, B.
    Del Prete, S.
    ANNALS OF ONCOLOGY, 2006, 17 : VII151 - VII151
  • [2] Temozolomide (TMZ) and radiation (XRT) for brain metastasis of solid tumors.
    Addeo, R.
    Montella, L.
    Guarrasi, R.
    Dello Russo, A.
    Faiola, V.
    Del Prete, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 68S - 68S
  • [3] Temozolomide (TMZ) and radiation (XRT) for aggressive pediatric malignancies
    Loh, KC
    Willett, J
    Meltzer, H
    Roberts, W
    Kerlin, B
    Kadota, R
    Levy, M
    Geddis, A
    Schiff, D
    Martin, L
    Yu, A
    Kung, F
    Spear, NA
    NEURO-ONCOLOGY, 2004, 6 (04) : 461 - 462
  • [4] PHASE II TRIAL OF TEMOZOLOMIDE (TMZ) FOR LEPTOMENINGEAL METASTASES IN SOLID TUMORS
    Segura, PedroPerez
    Gil, M.
    Balana, C.
    Chacon, I.
    Munoz, J.
    Martin, M.
    NEURO-ONCOLOGY, 2010, 12 : 39 - 40
  • [5] Temozolomide (TMZ) and radiation (XRT) for aggressive pediatric CNS malignancies.
    Loh, KC
    Willert, J
    Meltzer, H
    Roberts, W
    Kerlin, B
    Kung, F
    Levy, M
    Kadota, R
    Yu, A
    Spear, MA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 815S - 815S
  • [6] Low protracted dose of temozolomide (TMZ) and concurrent radiotherapy for brain metastasis of solid tumors
    Addeo, R.
    Faiola, V.
    Cennamo, G.
    Guarrasi, R.
    Montella, L.
    Del Prete, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Bevacizumab (BEV) in combination with temozolomide (TMZ) and radiation therapy (XRT) followed by BEV, TMZ, and irinotecan for newly diagnosed glioblastoma multiforme (GBM)
    Vredenburgh, J. J.
    Desjardins, A.
    Reardon, D. A.
    Peters, K.
    Kirkpatrick, J.
    Herndon, J. E.
    Marcello, J.
    Bailey, L.
    Threatt, S.
    Friedman, H. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study
    Christodoulou, C
    Bafaloukos, D
    Linardou, H
    Aravantinos, G
    Bamias, A
    Carina, M
    Klouvas, G
    Skarlos, D
    JOURNAL OF NEURO-ONCOLOGY, 2005, 71 (01) : 61 - 65
  • [9] Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study
    Christos Christodoulou
    Dimitrios Bafaloukos
    Helen Linardou
    Gerassimos Aravantinos
    Aristotelis Bamias
    Maria Carina
    George Klouvas
    Dimosthenis Skarlos
    Journal of Neuro-Oncology, 2005, 71 : 61 - 65
  • [10] A phase I study of bortezomib (BTZ) and temozolomide (TMZ) in patients with advanced solid tumors
    Portnow, J.
    Koehler, S.
    Cristea, M. C.
    Chow, W. A.
    Chung, V. M.
    Lim, D.
    Morgan, R.
    Shibata, S.
    Frankel, P. H.
    Synold, T. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345